FV activity and antigen data from the families described in this study
. | FV mutation . | Genotype* . | FV activity (%) . | FV antigen (%) . |
---|---|---|---|---|
Normal plasma | — | — | 60-120 | 70-130† |
Patient 1 | 8 bp deletion nts 1130-1139 & A5279G, Y1702C in trans | Compound heterozygous | < 1 | < 3.1 |
Patient 2 | 1 bp deletion nts 4291/4294 | Homozygous | < 1 | < 3.1 |
Father | Heterozygous | 57 | 56 | |
Mother | Heterozygous | 52 | 47 | |
Patient 3 | C2491T, Q773Term | Homozygous | < 1 | ND |
Patient 4 | A1102T, K310Term | Heterozygous | 34 | 51 |
Spouse | N | 125 | 136 | |
Child 1 | Heterozygous | 62 | 69 | |
Child 2 | Heterozygous | 60 | 64 | |
Child 3 | N | 109 | 142 | |
Child 4 | N | 93 | 136 | |
Patient 5 (III-1) | T1927C, C585R | Heterozygous | 52 | 65 |
Father (II-4) | N | 100 | 104 | |
Mother (II-3) | Heterozygous | 59 | 68 | |
Sister (III-2) | Heterozygous | 39 | 38 | |
Uncle (II-2) | Heterozygous | 55 | 59 | |
Aunt (II-1) | Heterozygous | ND | 66 |
. | FV mutation . | Genotype* . | FV activity (%) . | FV antigen (%) . |
---|---|---|---|---|
Normal plasma | — | — | 60-120 | 70-130† |
Patient 1 | 8 bp deletion nts 1130-1139 & A5279G, Y1702C in trans | Compound heterozygous | < 1 | < 3.1 |
Patient 2 | 1 bp deletion nts 4291/4294 | Homozygous | < 1 | < 3.1 |
Father | Heterozygous | 57 | 56 | |
Mother | Heterozygous | 52 | 47 | |
Patient 3 | C2491T, Q773Term | Homozygous | < 1 | ND |
Patient 4 | A1102T, K310Term | Heterozygous | 34 | 51 |
Spouse | N | 125 | 136 | |
Child 1 | Heterozygous | 62 | 69 | |
Child 2 | Heterozygous | 60 | 64 | |
Child 3 | N | 109 | 142 | |
Child 4 | N | 93 | 136 | |
Patient 5 (III-1) | T1927C, C585R | Heterozygous | 52 | 65 |
Father (II-4) | N | 100 | 104 | |
Mother (II-3) | Heterozygous | 59 | 68 | |
Sister (III-2) | Heterozygous | 39 | 38 | |
Uncle (II-2) | Heterozygous | 55 | 59 | |
Aunt (II-1) | Heterozygous | ND | 66 |